UBS Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-106
| Closed | -$1.4K | – | 9119 |
|
|
2024
Q1 | $1.4K | Sell |
106
-192
| -64% | -$2.54K | ﹤0.01% | 6969 |
|
|
2023
Q4 | $4.5K | Buy |
298
+164
| +122% | +$2.48K | ﹤0.01% | 6646 |
|
|
2023
Q3 | $2.01K | Buy |
+134
| New | +$2.01K | ﹤0.01% | 6639 |
|
|
2023
Q2 | – | Sell |
-301
| Closed | -$3.53K | – | 9019 |
|
|
2023
Q1 | $3.53K | Sell |
301
-364
| -55% | -$4.27K | ﹤0.01% | 7209 |
|
|
2022
Q4 | $10.2K | Buy |
665
+62
| +10% | +$955 | ﹤0.01% | 7358 |
|
|
2022
Q3 | $4K | Sell |
603
-832
| -58% | -$5.52K | ﹤0.01% | 8358 |
|
|
2022
Q2 | $13K | Buy |
1,435
+1,294
| +918% | +$11.7K | ﹤0.01% | 6561 |
|
|
2022
Q1 | $4K | Buy |
141
+140
| +14,000% | +$3.97K | ﹤0.01% | 8317 |
|
|
2021
Q4 | $0 | Sell |
1
-223
| -100% | – | ﹤0.01% | 9660 |
|
|
2021
Q3 | $20K | Buy |
224
+221
| +7,367% | +$19.7K | ﹤0.01% | 6044 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 8774 |
|
|
2021
Q1 | $0 | Sell |
3
-137
| -98% | – | ﹤0.01% | 8396 |
|
|
2020
Q4 | $12K | Sell |
140
-354
| -72% | -$30.3K | ﹤0.01% | 6347 |
|
|
2020
Q3 | $31K | Sell |
494
-89
| -15% | -$5.59K | ﹤0.01% | 5122 |
|
|
2020
Q2 | $51K | Buy |
583
+58
| +11% | +$5.07K | ﹤0.01% | 5009 |
|
|
2020
Q1 | $59K | Buy |
525
+28
| +6% | +$3.15K | ﹤0.01% | 4819 |
|
|
2019
Q4 | $122K | Buy |
497
+233
| +88% | +$57.2K | ﹤0.01% | 4873 |
|
|
2019
Q3 | $91K | Buy |
264
+82
| +45% | +$28.3K | ﹤0.01% | 4895 |
|
|
2019
Q2 | $168K | Sell |
182
-374
| -67% | -$345K | ﹤0.01% | 4209 |
|
|
2019
Q1 | $887K | Sell |
556
-755
| -58% | -$1.2M | ﹤0.01% | 3017 |
|
|
2018
Q4 | $2.45M | Buy |
1,311
+1,069
| +442% | +$2M | ﹤0.01% | 2281 |
|
|
2018
Q3 | $571K | Buy |
242
+201
| +490% | +$474K | ﹤0.01% | 3562 |
|
|
2018
Q2 | $142K | Sell |
41
-840
| -95% | -$2.91M | ﹤0.01% | 4328 |
|
|
2018
Q1 | $2.5M | Buy |
881
+178
| +25% | +$505K | ﹤0.01% | 2392 |
|
|
2017
Q4 | $1.81M | Buy |
703
+31
| +5% | +$79.8K | ﹤0.01% | 2593 |
|
|
2017
Q3 | $1.91M | Buy |
672
+358
| +114% | +$1.02M | ﹤0.01% | 2530 |
|
|
2017
Q2 | $742K | Buy |
314
+194
| +162% | +$458K | ﹤0.01% | 3112 |
|
|
2017
Q1 | $303K | Sell |
120
-242
| -67% | -$611K | ﹤0.01% | 3590 |
|
|
2016
Q4 | $818K | Buy |
362
+188
| +108% | +$425K | ﹤0.01% | 2967 |
|
|
2016
Q3 | $435K | Buy |
174
+69
| +66% | +$173K | ﹤0.01% | 3231 |
|
|
2016
Q2 | $322K | Buy |
105
+10
| +11% | +$30.7K | ﹤0.01% | 3453 |
|
|
2016
Q1 | $302K | Sell |
95
-251
| -73% | -$798K | ﹤0.01% | 3494 |
|
|
2015
Q4 | $1.78M | Sell |
346
-314
| -48% | -$1.61M | ﹤0.01% | 2264 |
|
|
2015
Q3 | $2.1M | Sell |
660
-135
| -17% | -$430K | ﹤0.01% | 2098 |
|
|
2015
Q2 | $3.18M | Sell |
795
-62
| -7% | -$248K | ﹤0.01% | 1962 |
|
|
2015
Q1 | $3.42M | Sell |
857
-716
| -46% | -$2.86M | ﹤0.01% | 1897 |
|
|
2014
Q4 | $7.72M | Buy |
+1,573
| New | +$7.72M | 0.01% | 1308 |
|